SS
KNSA icon

SBI Securities’s Kiniksa Pharmaceuticals KNSA Stock Holding History

SBI Securities’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73K Buy
74
+64
+640% +$3.32K ﹤0.01% 2202
2026
Q1 		$482 Sell
10
-90
-90% -$3.99K ﹤0.01% 2906
2025
Q4 		$4.13K Hold
100
– – ﹤0.01% 2101
2025
Q3 		$3.88K Sell
100
-10
-9% -$325 ﹤0.01% 2147
2025
Q2 		$3.04K Hold
110
– – ﹤0.01% 2212
2025
Q1 		$2.44K Hold
110
– – ﹤0.01% 2211
2024
Q4 		$2.18K Buy
+110
New +$2.51K ﹤0.01% 2281

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

SBI Securities's KNSA Position: Q2 2026 in Review

SBI Securities increased its Kiniksa Pharmaceuticals (KNSA) stake by 640% in Q2 2026, buying an estimated $3.32K and bringing the position to 74 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

SBI Securities first reported a position in KNSA in Q4 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • SBI Securities held 74 shares of Kiniksa Pharmaceuticals worth $4.73K as of Q2 2026.
  • SBI Securities bought 64 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $3.32K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2202 holding.
  • SBI Securities first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.